NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Promore Pharma AB (publ) (ST: PROMO)
PROMO Technical Analysis
5
As on 19th Mar 2024 PROMO STOCK Price closed @ 10.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.65 & Strong Buy for SHORT-TERM with Stoploss of 0.93 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PROMOSTOCK Price
Open | 9.90 | Change | Price | % |
High | 11.00 | 1 Day | 0.10 | 0.98 |
Low | 9.85 | 1 Week | -1.70 | -14.17 |
Close | 10.30 | 1 Month | -10.40 | -50.24 |
Volume | 6782 | 1 Year | 9.25 | 880.95 |
52 Week High 58.24 | 52 Week Low 0.05 |
ST Sweden Most Active Stocks
FING-B | 0.03 | -25.00% |
WYLD | 0.01 | 0.00% |
SBB-B | 4.10 | 0.49% |
TELIA | 30.18 | -0.26% |
HDW-B | 0.00 | % |
CYB1 | 0.01 | 0.00% |
NIBE-B | 42.17 | 0.19% |
LUNE | 21.97 | 6.65% |
ERIC-B | 89.10 | -0.13% |
ABLI | 0.42 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
PROMO Daily Charts |
PROMO Intraday Charts |
Whats New @ Bazaartrend |
PROMO Free Analysis |
|
PROMO Important Levels Intraday
RESISTANCE | 12.52 |
RESISTANCE | 11.81 |
RESISTANCE | 11.37 |
RESISTANCE | 10.93 |
SUPPORT | 9.67 |
SUPPORT | 9.23 |
SUPPORT | 8.79 |
SUPPORT | 8.08 |
PROMO Forecast December 2024
4th UP Forecast | 11.73 |
3rd UP Forecast | 11.27 |
2nd UP Forecast | 10.99 |
1st UP Forecast | 10.7 |
1st DOWN Forecast | 9.9 |
2nd DOWN Forecast | 9.61 |
3rd DOWN Forecast | 9.33 |
4th DOWN Forecast | 8.87 |
PROMO Weekly Forecast
4th UP Forecast | 10.40 |
3rd UP Forecast | 10.37 |
2nd UP Forecast | 10.35 |
1st UP Forecast | 10.33 |
1st DOWN Forecast | 10.27 |
2nd DOWN Forecast | 10.25 |
3rd DOWN Forecast | 10.23 |
4th DOWN Forecast | 10.20 |
PROMO Forecast2024
4th UP Forecast | 165.62 |
3rd UP Forecast | 115.81 |
2nd UP Forecast | 85.02 |
1st UP Forecast | 54.23 |
1st DOWN Forecast | -33.63 |
2nd DOWN Forecast | -64.42 |
3rd DOWN Forecast | -95.21 |
4th DOWN Forecast | -145.02 |
Promore Pharma AB (publ) ( ST Sweden Symbol : PROMO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PROMO Other Details
Segment | EQ | |
Market Capital | 95806528.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
PROMO Address
PROMO Latest News
PROMO Business Profile
Promore Pharma AB (publ), a biopharmaceutical company, develops therapeutic peptides for the bio-active wound care market in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand, which is in Phase III trial; and LL-37, which is in Phase IIb clinical studies for treating patients with venous leg ulcers and for the treatment of diabetic foot ulcers. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is based in Solna, Sweden. Address: Fogdevreten 2, Solna, Sweden, 171 65
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service